WHITEHAWK THERAPEUTICS, INC. Earnings Per Share (Basic)
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Earnings Per Share (Basic) of -$0.20 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.20.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.32, a 117.39% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.26.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.76.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$0.33.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$2.36.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$2.44.
- WHITEHAWK THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$2.69.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.20 10-Q · filed 2026-08-06 | -$0.51 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$0.32 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.33 10-K · filed 2026-03-12 | |||
| 2025-09-30 | -$0.26 10-Q · filed 2025-11-06 | $0.04 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.76 10-Q · filed 2026-08-06 | $0.37 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $1.84 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$2.36 10-K · filed 2026-03-12 | |||
| 2024-09-30 | -$0.46 10-Q · filed 2025-11-06 | -$1.68 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.54 10-Q · filed 2025-08-07 | -$1.22 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.68 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$2.44 10-K · filed 2025-03-28 | |||
| 2023-09-30 | -$0.60 10-Q · filed 2024-11-06 | -$1.84 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$0.67 10-Q · filed 2024-08-07 | -$1.23 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.57 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$2.69 10-K · filed 2024-03-13 | |||
| 2022-09-30 | -$0.68 10-Q · filed 2023-11-08 | -$2.21 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$0.87 10-Q · filed 2023-08-09 | -$1.53 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$0.66 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$0.76 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$6.76 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$9.76 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$12.41 10-K · filed 2023-03-29 |
| 2021-09-30 | -$9.17 10-Q · filed 2022-11-09 | -$15.21 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$19.37 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.60 10-Q · filed 2022-08-10 | -$2.76 10-Q · filed 2022-08-10 | ||
| 2020-06-30 | $0.23 derived: net income ÷ weighted average shares · filed 2021-08-11 | $0.13 derived: net income ÷ weighted average shares · filed 2021-08-11 | ||
| 2020-03-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-05-17 | |||
| 2019-09-30 | -$0.11 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$0.25 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$0.46 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$0.67 derived: net income ÷ weighted average shares · filed 2020-11-10 |
| 2019-06-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2020-08-12 | -$0.35 derived: net income ÷ weighted average shares · filed 2020-08-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2020-08-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2020-08-12 |
| 2019-03-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$0.42 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-05-07 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-05-07 |
| 2018-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-03-16 | $0.07 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-03-16 |
| 2018-09-30 | $0.28 derived: net income ÷ weighted average shares · filed 2020-03-16 | $0.16 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.06 derived: net income ÷ weighted average shares · filed 2019-11-07 | |
| 2018-06-30 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.49 derived: net income ÷ weighted average shares · filed 2020-03-16 | ||
| 2018-03-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2020-03-16 | |||
| 2017-09-30 | -$0.17 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$0.81 derived: net income ÷ weighted average shares · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |